US 10610125
Methods and compositions for cell-proliferation-related disorders
granted A61KA61K31/41A61K31/426
Quick answer
US patent 10610125 (Methods and compositions for cell-proliferation-related disorders) held by Agios Pharmaceuticals, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/41, A61K31/426, A61K45/06, A61P